Educational Wellness Information Only
This platform provides peer-reviewed research summaries and educational content about peptides for wellness and optimization purposes. Nothing on this site is intended as medical advice, diagnosis, or treatment. We do not claim any peptide can diagnose, treat, cure, or prevent any disease. Always consult a licensed healthcare provider before beginning any wellness protocol.
Statements on this site have not been evaluated by the FDA. Compounded preparations are subject to applicable state and federal regulations. Availability and eligibility vary.
Leuprolide (Lupron) Peptide
GnRH agonist used for prostate cancer, endometriosis, and precocious puberty.
What is Leuprolide (Lupron)?
Leuprolide (Lupron) is a gnrh agonist · hormonal peptide studied for advanced prostate cancer and endometriosis. Below is an educational overview of Leuprolide (Lupron) peptide benefits, mechanism, common research protocols, dosage references, and known side effects.
Plain-Language Label Highlights
Brand names: Lupron, Eligard, Fensolvi
Advanced prostate cancer, endometriosis, uterine fibroids, central precocious puberty.
A depot injection that initially raises and then deeply lowers sex hormones (testosterone/estrogen) by shutting down the pituitary signal.
- •Hot flashes
- •Injection-site reactions
- •Bone pain (initial flare)
- •Fatigue
- •Mood changes
- •Initial testosterone/estrogen surge worsening symptoms
- •Bone density loss with long-term use
- •Cardiovascular and metabolic effects
- •QT prolongation
- •Pregnancy
- •Known hypersensitivity to GnRH analogs
- •Uncontrolled cardiac arrhythmia (caution)
Educational summary of the FDA prescribing information. Not a substitute for the full label or medical advice. Always discuss with a licensed prescriber.
Leuprolide (Lupron) Mechanism of Action
Synthetic nonapeptide GnRH agonist. Continuous administration desensitizes pituitary GnRH receptors, suppressing LH/FSH and downstream sex hormone production (medical castration).
Leuprolide (Lupron) Research Areas & Benefits
Leuprolide (Lupron) Dosage & Common Research Protocols
7.5 mg IM monthly, or 22.5 mg every 3 months.
Pediatric weight-based depot dosing.
Protocols summarized for educational reference from published research. Not dosing guidance.
Leuprolide (Lupron) Studies & Cited Research
Leuprolide in metastatic prostate cancer
Established equivalence to orchiectomy for androgen suppression.
Why we trust this source: Published in a peer-reviewed scientific journal with editorial and reviewer oversight.
Citations are linked to PubMed, Google Scholar, and Crossref searches so you can verify the source independently. All references are reviewed during our editorial passes (last reviewed June 1, 2026).
Leuprolide (Lupron) Side Effects & Safety Considerations
- •FDA-approved.
- •Initial testosterone flare; hot flashes, bone density loss with long-term use.
Common questions about Leuprolide (Lupron)
More Hormonal peptides · See all 14
Educational Information Only — Not Medical Advice
All content on this page is for educational and informational purposes only. It is not medical advice, diagnosis, or treatment. We make no claims that any peptide can diagnose, treat, cure, or prevent any disease. Peptides discussed are not FDA-approved for the indications listed unless explicitly stated otherwise.
Always consult a licensed healthcare provider before beginning any wellness protocol. Statements have not been evaluated by the FDA. Compounded preparations are subject to applicable state and federal regulations. Availability, eligibility, and pricing may vary.
Ask the Library
Ask anything about peptides — answers come from our curated reference library with citations.